Pituitary adenylate cyclase-activating polypeptide (PACAP) in fetal cord blood

Stephen J Winters1, Jeffrey C King2, Carol K Brees2

  • 1Department of Medicine, University of Louisville, United States.

Insights

This study found no significant impact of labor stress on fetal pituitary adenylate cyclase-activating peptide (PACAP) levels in cord blood. Further research is needed to clarify PACAP's role in pregnancy and childbirth.

Area of Science:

  • Neuroendocrinology
  • Reproductive Biology
  • Perinatal Medicine

Background:

  • Pituitary adenylate cyclase-activating peptide (PACAP) is a peptide found in the brain, nervous system, and placenta.
  • PACAP influences the 'fight-or-flight' response, affecting cortisol and catecholamine production.
  • Its role in fetal development and response to labor stress is not fully understood.

Purpose of the Study:

  • To investigate the effect of labor as a stressor on fetal PACAP levels.
  • To test the hypothesis that PACAP levels increase with labor, abnormal fetal heart tracing, or fetal growth impairment.

Main Methods:

  • Collected fetal cord venous blood samples immediately after vaginal or Cesarean delivery.
  • Stored samples at -80°C for PACAP immunoassay.
  • Analyzed delivery data, including birth weight and Apgar scores.

Main Results:

  • Fetal cord blood PACAP levels were similar between males and females.
  • A trend suggested higher PACAP levels in neonates delivered via Cesarean section compared to vaginal delivery.
  • PACAP levels did not correlate with birth weight, Apgar scores, or the presence of labor.

Conclusions:

  • Labor stress did not appear to affect fetal PACAP levels in this study.
  • PACAP and its receptors are present in the placenta, and PACAP is found in cord blood.
  • More research is required to elucidate PACAP's function during gestation and parturition.
Abstract